Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

Interleukin-9 is a pleiotropic cytokine associated with allergic inflammation 1 and is a therapeutic target in patients with asthma. Its expression and that of the interleukin-9 receptor are greater ...

In a finding that could have important implications for the millions of Americans who suffer from asthma, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) have ...

For patients with moderate to severe asthma, blockade with itepekimab, a new human IgG4P monoclonal antibody against the upstream alarmin interleukin-33, led to a reduction in events that indicate ...

—Treating increasing asthma severity represents 80% of asthma care costs. So what can be done to bring down exacerbation rates? Biomarkers provide some clues. Reviewed by Ware Kuschner, MD, Professor ...

Researchers at the Keck School of Medicine of the University of Southern California have discovered that a protein called Piezo1 prevents type 2 innate lymphoid cells (ILC2s) in the lung from becoming ...

“What we're trying to do is connect the dots between early life infections and ILC2s as the initial drivers of asthma susceptibility and asthma pathogenesis,” said Anna Beaudin, a hematopoietic stem ...

Please provide your email address to receive an email when new articles are posted on . Sex and gender can influence the pathogenesis, clinical course, diagnosis, treatment and management of asthma, ...

As the prevalence of asthma continues to increase, the financial impact on the healthcare costs of the United States does as well. Managed care pharmacists are ideally situated to unite the shared ...